Date: 18 April 2023
Time: 9:30 – 15:00
Location: Design Offices Heidelberg Colours
Antigen-Specific Immune Monitoring of T-cells: Applications in infectious disease and immuno-oncology
In April, Immudex will be hosting a seminar day in Heidelberg where researchers from the area will give presentations about their research in the area of antigen-specific immune monitoring of T cells.
This event is free to attend but the number of places is limited so please register to secure your seat.
Register Now
Program
|
09:30-10:15 |
Welcome Coffee and desk registration |
| 10:30-11:00 |
Dr. Isabel Poschke, Head of Immune Monitoring Unit. German Cancer Research Center (DKFZ), Heidelberg Next-generation immune monitoring in immuno-oncology trials – repertoires, receptors, reactivities |
| 11:00-11:30 |
Dr. Viktor Umansky, Group Leader, German Cancer Research Center (DKFZ), Heidelberg and University Medical Center (UMM) Mannheim. T cell immune responses against SARS-CoV-2 upon vaccination |
|
11:30-12:00 |
Dr. Krishna Das, Principal Scientist at ViraTherapeutics GmbH, Innsbruck, Austria Monitoring antigen-specific T cell responses for oncolytic virus therapy |
|
12:00-13:00 |
Lunch & Get Together |
|
13:00-13:30 |
Speaker to be confirmed, Immudex ApS Evaluating Antigen Specificity and its Impact on Immunity using Dextramer® Technology |
|
13:30-14:00 |
Dr. Marten Mayer, Senior Scientist, Department of Medical Oncology (Prof. Dr. Dirk Jäger), National Center for Tumor Diseases (NCT), Heidelberg and Antigen Presentation & T/NK Cell Activation (PD Dr. Frank Momburg), German Cancer Research Center (DKFZ), Heidelberg Towards cancer neoepitope-specific TCR T cell therapy using recombinant MHC molecules |
| 14:30-15:00 |
Dr. Sebastian Klein, Dept. of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology Hannover Medical School (MHH) Single-cell sequencing of antigen-specific CD8+ T cells in chronic viral infection |